Literature DB >> 15346079

Scapular chondrosarcomas have high rates of local recurrence and metastasis.

Michaela M Schneiderbauer1, Charlene Blanchard, Rachel Gullerud, William S Harmsen, Michael G Rock, Thomas C Shives, Franklin H Sim, Sean P Scully.   

Abstract

This is the first report of a large series of patients with scapular chondrosarcomas. The grade distributions, locations of the tumors in the scapula, surgical techniques, status of margins, chondrosarcoma subtypes, Enneking stages, adjuvant therapies, local recurrence rates, metastasis rates, and survival prognoses of patients with scapular chondrosarcoma were evaluated. Forty-seven patients treated between 1921 and 1999 were analyzed retrospectively. Grade 3 disease was significantly associated with a poorer survival prognosis when compared with Grades 1 or 2 disease. Patients with tumors smaller than 5 cm were treated mainly with partial scapulectomy, and patients with tumors larger than 5 cm often were treated with total scapulectomy. The survival prognoses of patients with intralesional resections at initial surgery showed a tendency toward poorer survival when compared with patients with wide resections at initial surgery. Metastasis and local recurrence (21.3% and 40.4%) were higher in scapular chondrosarcomas than rates reported for patients with general chondrosarcomas, and local recurrence or metastasis was associated with limited survival. The 5- and 15-year survival probabilities subsequent to diagnosis were 79% and 53%, respectively. The high rates of local recurrence and metastasis likely were caused by the difficult anatomic relationships encountered during scapular resections. This study shows the importance of wide margins which must be achieved to provide local disease control.

Entities:  

Mesh:

Year:  2004        PMID: 15346079     DOI: 10.1097/01.blo.0000136905.44818.65

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  8 in total

1.  Reconstruction with scapular hemiarthroplasty endoprosthesis after scapulectomy for malignant tumour.

Authors:  Li Min; Yong Zhou; Fan Tang; Wenli Zhang; Yi Luo; Hong Duan; Chongqi Tu
Journal:  Int Orthop       Date:  2017-03-06       Impact factor: 3.075

Review 2.  The imaging of cartilaginous bone tumours. II. Chondrosarcoma.

Authors:  H Douis; A Saifuddin
Journal:  Skeletal Radiol       Date:  2012-10-04       Impact factor: 2.199

3.  Functional and oncological outcome after surgical resection of the scapula and clavicle for primary chondrosarcoma.

Authors:  S P F T Nota; M J A M Russchen; K A Raskin; H J Mankin; F J Hornicek; J H Schwab
Journal:  Musculoskelet Surg       Date:  2016-11-29

4.  Grade I chondrosarcoma of bone: the Münster experience.

Authors:  Arne Streitbürger; Helmut Ahrens; Maurice Balke; Horst Buerger; Winfried Winkelmann; Georg Gosheger; Jendrik Hardes
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-15       Impact factor: 4.553

5.  Adiponectin promotes VEGF-A-dependent angiogenesis in human chondrosarcoma through PI3K, Akt, mTOR, and HIF-α pathway.

Authors:  Hsiang-Ping Lee; Chih-Yang Lin; Jhao-Sheng Shih; Yi-Chin Fong; Shih-Wei Wang; Te-Mao Li; Chih-Hsin Tang
Journal:  Oncotarget       Date:  2015-11-03

6.  Surgical technique and clinical results for scapular allograft reconstruction following resection of scapular tumors.

Authors:  Kaiwei Zhang; Hong Duan; Zhou Xiang; Chongqi Tu
Journal:  J Exp Clin Cancer Res       Date:  2009-04-01

7.  Basic fibroblast growth factor promotes VEGF-C-dependent lymphangiogenesis via inhibition of miR-381 in human chondrosarcoma cells.

Authors:  Huey-En Tzeng; An-Chen Chang; Chun-Hao Tsai; Shih-Wei Wang; Chih-Hsin Tang
Journal:  Oncotarget       Date:  2016-06-21

8.  Application of a three-dimensional printed segmental scapula prosthesis in the treatment of scapula tumors.

Authors:  Linglong Deng; Xing Zhao; Chi Wei; Wenqiang Qu; Li Yu; Shaobo Zhu
Journal:  J Int Med Res       Date:  2019-10-03       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.